Regulator Sets Tough Tone At Indian Manufacturers’ Meeting
This article was originally published in PharmAsia News
Executive Summary
If the annual meeting of the Indian Drug Manufacturers' Association (IDMA) is anything to go by, then the drug regulatory regime in the country appears set for a significant makeover.